Can Tesamorelin Improve Cardiovascular Outcomes beyond Lipid Changes in non-HIV Populations?
Tesamorelin may improve cardiovascular outcomes by reducing inflammatory visceral fat and mitigating liver fibrosis, beyond lipid changes.
HRTioJuly 25, 2025